NATCOPHARM

Natco Pharma Shareholding Pattern

₹811.60-1.46%
Market cap
₹14,537 crore
P/E
12.7
P/B
1.58
ROE
16.9%
Dividend yield
0.18%

As of 30-JUN-2026, promoters held 49.42% of Natco Pharma (0.00 pp from 31-MAR-2026), foreign institutional investors 16.99%, domestic institutions 5.62% and the public 27.97%.

Natco Pharma shareholding pattern

Percentage of shares held, by quarter, newest first.

Natco Pharma shareholding by category (% of equity)
Holder30-JUN-202631-MAR-202631-DEC-202530-SEP-202530-JUN-202531-MAR-2025Change
Promoters49.42%49.42%49.48%49.48%49.56%n/a0.00 pp
Foreign institutions (FII/FPI)16.99%17.37%15.16%14.09%15.51%n/a-0.38 pp
Domestic institutions (DII)5.62%5.46%5.39%5.87%5.82%n/a+0.16 pp
Government0.00%0.00%0.00%0.00%0.00%n/a0.00 pp
Public27.97%27.75%29.96%30.56%29.11%n/a+0.22 pp

Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 7 October 2026. How this data is compiled.

Natco Pharma shareholding pattern — frequently asked questions

What is the promoter holding in Natco Pharma?

Promoters held 49.42% of Natco Pharma as of 30-JUN-2026, unchanged from 49.42% in 31-MAR-2026.

How much do FIIs hold in Natco Pharma?

Foreign institutional investors held 16.99% of Natco Pharma as of 30-JUN-2026, a change of -0.38 pp from the previous quarter.

How much do domestic institutions hold in Natco Pharma?

Domestic institutional investors, including mutual funds and insurers, held 5.62% of Natco Pharma as of 30-JUN-2026 (+0.16 pp from the previous quarter).

Who owns Natco Pharma?

As of 30-JUN-2026, Natco Pharma's shareholders were promoters (49.42%), foreign institutional investors 16.99%, domestic institutions 5.62% and the public 27.97%, as filed with the stock exchanges.

Same Data For Peers

💡 LearnHow to read a shareholding pattern →

Trade Natco Pharma With ATS

Track NATCOPHARM live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Natco Pharma share priceOpen a demat account →Brokerage calculator

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.